Stay updated on 89Zr-Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 89Zr-Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-lapse notice along with Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T11:32:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide government funding lapse notice indicating possible delays in updates and support availability. Updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:29:13.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The changes are minor UI/text updates: a new 'Show glossary' option and new footer/version details ('Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), plus removal of older labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:21:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T02:22:42.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section featuring North Holland (Amsterdam, Netherlands) and removed the old North Holland Locations entry; the HHS Vulnerability Disclosure link was removed. The footer now shows Revision: v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:09:21.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:00.000Z thumbnail image

Stay in the know with updates to 89Zr-Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.